600351.SS · 亚宝药业
China A-shares · RS rating 91 · As of 2026-10-14
| Price | 6.88 CNY |
|---|---|
| 1-day change | -0.3% |
| RS rating (overall / 1M / 3M / 12M) | 91 / 85 / 80 / 73 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 41 / 47 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +0.2% |
| Distance from 52-week high | +5.4% |
| Market cap (USD) | $705.8M |